Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Steven Abman to Administration, Inhalation

This is a "connection" page, showing publications Steven Abman has written about Administration, Inhalation.

 
Connection Strength
  
 
 
3.144
  
  1. Chandrasekharan P, Lakshminrusimha S, Abman SH. When to say no to inhaled nitric oxide in neonates? Semin Fetal Neonatal Med. 2021 04; 26(2):101200.
    View in: PubMed
    Score: 0.161
  2. Lakshminrusimha S, Kinsella JP, Krishnan US, Van Meurs K, Edwards EM, Bhatt DR, Chandrasekharan P, Oei JL, Manja V, Ramanathan R, Abman SH. Just Say No to iNO in Preterms-Really? J Pediatr. 2020 03; 218:243-252.
    View in: PubMed
    Score: 0.149
  3. Kinsella JP, Steinhorn RH, Krishnan US, Feinstein JA, Adatia I, Austin ED, Rosenzweig EB, Everett AD, Fineman JR, Hanna BD, Hopper RK, Humpl T, Ivy DD, Keller RL, Mullen MP, Raj JU, Wessel DL, Abman SH. Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. J Pediatr. 2016 Mar; 170:312-4.
    View in: PubMed
    Score: 0.113
  4. Mourani PM, Abman SH. Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia. Clin Perinatol. 2015 Dec; 42(4):839-55.
    View in: PubMed
    Score: 0.112
  5. Kinsella JP, Cutter GR, Steinhorn RH, Nelin LD, Walsh WF, Finer NN, Abman SH. Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns. J Pediatr. 2014 Dec; 165(6):1104-1108.e1.
    View in: PubMed
    Score: 0.103
  6. Abman SH. Inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Handb Exp Pharmacol. 2013; 218:257-76.
    View in: PubMed
    Score: 0.092
  7. Tourneux P, Markham N, Seedorf G, Balasubramaniam V, Abman SH. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats. Am J Physiol Lung Cell Mol Physiol. 2009 Dec; 297(6):L1103-11.
    View in: PubMed
    Score: 0.074
  8. Ivy DD, Doran AK, Smith KJ, Mallory GB, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol. 2008 Jan 15; 51(2):161-9.
    View in: PubMed
    Score: 0.065
  9. Tang JR, Seedorf G, Balasubramaniam V, Maxey A, Markham N, Abman SH. Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition. Am J Physiol Lung Cell Mol Physiol. 2007 Nov; 293(5):L1271-80.
    View in: PubMed
    Score: 0.064
  10. Kinsella JP, Abman SH. Inhaled nitric oxide in the premature newborn. J Pediatr. 2007 Jul; 151(1):10-5.
    View in: PubMed
    Score: 0.063
  11. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006 Jul 27; 355(4):354-64.
    View in: PubMed
    Score: 0.059
  12. Balasubramaniam V, Maxey AM, Morgan DB, Markham NE, Abman SH. Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol. 2006 Jul; 291(1):L119-27.
    View in: PubMed
    Score: 0.057
  13. Balasubramaniam V, Maxey A, Abman S. Inhaled nitric oxide reverses hypoxia induced lung hypoplasia in endothelial nitric oxide synthase-deficient mice. Chest. 2005 Dec; 128(6 Suppl):613S-614S.
    View in: PubMed
    Score: 0.056
  14. Kinsella JP, Parker TA, Davis JM, Abman SH. Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med. 2005 Sep 15; 172(6):745-9.
    View in: PubMed
    Score: 0.055
  15. Kinsella JP, Ivy DD, Abman SH. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension. Semin Perinatol. 2005 Apr; 29(2):123-8.
    View in: PubMed
    Score: 0.054
  16. Mourani PM, Ivy DD, Gao D, Abman SH. Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2004 Nov 01; 170(9):1006-13.
    View in: PubMed
    Score: 0.051
  17. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, Abman SH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol. 2004 Aug; 287(2):L344-51.
    View in: PubMed
    Score: 0.050
  18. Ivy DD, Parker D, Doran A, Parker D, Kinsella JP, Abman SH. Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension. Am J Cardiol. 2003 Oct 01; 92(7):886-90.
    View in: PubMed
    Score: 0.049
  19. Dyess NF, Palmer C, Soll RF, Clark RH, Abman SH, Kinsella JP. Practices and Outcomes from a Prospective, Multicenter Registry for Preterm Newborns with Pulmonary Hypertension. J Pediatr. 2023 11; 262:113614.
    View in: PubMed
    Score: 0.048
  20. Kinsella JP, Parker TA, Ivy DD, Abman SH. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr. 2003 Apr; 142(4):397-401.
    View in: PubMed
    Score: 0.047
  21. Abman SH, Kinsella JP. Inhaled ethyl nitrite gas for persistent pulmonary hypertension in infants. Lancet. 2002 Dec 21-28; 360(9350):2076-7; author reply 2077.
    View in: PubMed
    Score: 0.046
  22. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 2002 Jul; 87(1):F15-8.
    View in: PubMed
    Score: 0.045
  23. Cookson MW, Abman SH, Kinsella JP, Mandell EW. Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension. Semin Fetal Neonatal Med. 2022 08; 27(4):101367.
    View in: PubMed
    Score: 0.044
  24. Kinsella JP, Griebel J, Schmidt JM, Abman SH. Use of inhaled nitric oxide during interhospital transport of newborns with hypoxemic respiratory failure. Pediatrics. 2002 Jan; 109(1):158-61.
    View in: PubMed
    Score: 0.043
  25. Rairigh RL, Parker TA, Ivy DD, Kinsella JP, Fan ID, Abman SH. Role of inducible nitric oxide synthase in the pulmonary vascular response to birth-related stimuli in the ovine fetus. Circ Res. 2001 Apr 13; 88(7):721-6.
    View in: PubMed
    Score: 0.041
  26. Sch?fer M, Frank BS, Ivy DD, Abman SH, Stenmark KR, Mitchell MB, Browne LP, Barker AJ, Hunter KS, Kheyfets V, Miller-Reed K, Ing R, Morgan GJ, Truong U. Short-Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4-Dimensional-Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension. J Am Heart Assoc. 2021 04 20; 10(8):e020548.
    View in: PubMed
    Score: 0.041
  27. Kinsella JP, Abman SH. Inhaled nitric oxide: current and future uses in neonates. Semin Perinatol. 2000 Dec; 24(6):387-95.
    View in: PubMed
    Score: 0.040
  28. Kinsella JP, Abman SH. Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr. 2000 Jun; 136(6):717-26.
    View in: PubMed
    Score: 0.039
  29. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SH. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet. 1999 Sep 25; 354(9184):1061-5.
    View in: PubMed
    Score: 0.037
  30. Kinsella JP, Parker TA, Galan H, Sheridan BC, Abman SH. Independent and combined effects of inhaled nitric oxide, liquid perfluorochemical, and high-frequency oscillatory ventilation in premature lambs with respiratory distress syndrome. Chest. 1999 Jul; 116(1 Suppl):15S-16S.
    View in: PubMed
    Score: 0.036
  31. Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, Liu P, Eells PL, Griebel J, Baier M, Kinsella JP, Abman SH. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999 Apr; 134(4):406-12.
    View in: PubMed
    Score: 0.036
  32. Kinsella JP, Parker TA, Galan H, Sheridan BC, Abman SH. Independent and combined effects of inhaled nitric oxide, liquid perfluorochemical, and high-frequency oscillatory ventilation in premature lambs with respiratory distress syndrome. Am J Respir Crit Care Med. 1999 Apr; 159(4 Pt 1):1220-7.
    View in: PubMed
    Score: 0.036
  33. Kinsella JP, Abman SH. Recent developments in inhaled nitric oxide therapy of the newborn. Curr Opin Pediatr. 1999 Apr; 11(2):121-5.
    View in: PubMed
    Score: 0.036
  34. Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol. 2019 06; 46(2):291-310.
    View in: PubMed
    Score: 0.036
  35. Frank BS, Sch?fer M, Grenolds A, Ivy DD, Abman SH, Darst JR. Acute Vasoreactivity Testing during Cardiac Catheterization of Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. J Pediatr. 2019 05; 208:127-133.
    View in: PubMed
    Score: 0.035
  36. Ziegler JW, Ivy DD, Wiggins JW, Kinsella JP, Clarke WR, Abman SH. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med. 1998 Nov; 158(5 Pt 1):1388-95.
    View in: PubMed
    Score: 0.035
  37. Ivy DD, Griebel JL, Kinsella JP, Abman SH. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. J Pediatr. 1998 Sep; 133(3):453-6.
    View in: PubMed
    Score: 0.034
  38. Ivy DD, Ziegler JW, Kinsella JP, Wiggins JW, Abman SH. Hemodynamic effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Chest. 1998 Jul; 114(1 Suppl):17S.
    View in: PubMed
    Score: 0.034
  39. Kinsella JP, Abman SH. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group. Chest. 1998 Jul; 114(1 Suppl):100S.
    View in: PubMed
    Score: 0.034
  40. Abman SH, Kinsella JP. Inhaled nitric oxide therapy for pulmonary disease in pediatrics. Curr Opin Pediatr. 1998 Jun; 10(3):236-42.
    View in: PubMed
    Score: 0.034
  41. Parker TA, Kinsella JP, Abman SH. Response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: relationship to baseline oxygenation. J Perinatol. 1998 May-Jun; 18(3):221-5.
    View in: PubMed
    Score: 0.033
  42. Ivy DD, Kinsella JP, Ziegler JW, Abman SH. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg. 1998 Apr; 115(4):875-82.
    View in: PubMed
    Score: 0.033
  43. Kinsella JP, Abman SH. Controversies in the use of inhaled nitric oxide therapy in the newborn. Clin Perinatol. 1998 Mar; 25(1):203-17.
    View in: PubMed
    Score: 0.033
  44. Kinsella JP, Abman SH. Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn. Eur J Pediatr. 1998 Jan; 157 Suppl 1:S28-30.
    View in: PubMed
    Score: 0.033
  45. Abman SH. Role of inhaled nitric oxide in treatment of neonatal pulmonary hypertension. Zhongguo Yao Li Xue Bao. 1997 Nov; 18(6):542-5.
    View in: PubMed
    Score: 0.032
  46. Kinsella JP, Abman SH. Inhaled nitric oxide in the premature infant: animal models and clinical experience. Semin Perinatol. 1997 Oct; 21(5):418-25.
    View in: PubMed
    Score: 0.032
  47. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997 Jul; 131(1 Pt 1):55-62.
    View in: PubMed
    Score: 0.032
  48. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res. 1997 Apr; 41(4 Pt 1):457-63.
    View in: PubMed
    Score: 0.031
  49. Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM, Abman SH. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest. 1997 Mar 15; 99(6):1179-86.
    View in: PubMed
    Score: 0.031
  50. Cornfield DN, Abman SH. Inhalational nitric oxide in pulmonary parenchymal and vascular disease. J Lab Clin Med. 1996 Jun; 127(6):530-9.
    View in: PubMed
    Score: 0.029
  51. Kinsella JP, Abman SH. Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy. J Perinatol. 1996 Mar-Apr; 16(2 Pt 2 Su):S24-7.
    View in: PubMed
    Score: 0.029
  52. Abman SH, Kinsella JP. Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: the physiology matters! Pediatrics. 1995 Dec; 96(6):1153-5.
    View in: PubMed
    Score: 0.028
  53. Rosenberg AA, Kinsella JP, Abman SH. Cerebral hemodynamics and distribution of left ventricular output during inhalation of nitric oxide. Crit Care Med. 1995 Aug; 23(8):1391-7.
    View in: PubMed
    Score: 0.028
  54. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr. 1995 Jun; 126(6):853-64.
    View in: PubMed
    Score: 0.027
  55. Kinsella JP, Schmidt JM, Griebel J, Abman SH. Inhaled nitric oxide treatment for stabilization and emergency medical transport of critically ill newborns and infants. Pediatrics. 1995 May; 95(5):773-6.
    View in: PubMed
    Score: 0.027
  56. Abman SH, Kinsella JP. Inhaled nitric oxide therapy of pulmonary hypertension and respiratory failure in premature and term neonates. Adv Pharmacol. 1995; 34:457-74.
    View in: PubMed
    Score: 0.026
  57. Kinsella JP, Ivy DD, Abman SH. Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation. Am J Physiol. 1994 Nov; 267(5 Pt 2):H1955-61.
    View in: PubMed
    Score: 0.026
  58. Kinsella JP, Ivy DD, Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res. 1994 Sep; 36(3):402-8.
    View in: PubMed
    Score: 0.026
  59. Ivy DD, Wiggins JW, Badesch DB, Kinsella JP, Kelminson LL, Abman SH. Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension. Am J Cardiol. 1994 Aug 15; 74(4):414-6.
    View in: PubMed
    Score: 0.026
  60. Abman SH. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Curr Opin Pediatr. 1994 Jun; 6(3):239-47.
    View in: PubMed
    Score: 0.025
  61. Kinsella JP, Abman SH. Efficacy of inhalational nitric oxide therapy in the clinical management of persistent pulmonary hypertension of the newborn. Chest. 1994 Mar; 105(3 Suppl):92S-94S.
    View in: PubMed
    Score: 0.025
  62. Gadhia MM, Cutter GR, Abman SH, Kinsella JP. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr. 2014 Apr; 164(4):744-8.
    View in: PubMed
    Score: 0.025
  63. Kinsella JP, Abman SH. Methaemoglobin during nitric oxide therapy with high-frequency ventilation. Lancet. 1993 Sep 04; 342(8871):615.
    View in: PubMed
    Score: 0.024
  64. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993 Jul; 123(1):103-8.
    View in: PubMed
    Score: 0.024
  65. Kinsella JP, Abman SH. Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics. 1993 May; 91(5):997-8.
    View in: PubMed
    Score: 0.024
  66. Kinsella JP, Toews WH, Henry D, Abman SH. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J Pediatr. 1993 May; 122(5 Pt 1):803-6.
    View in: PubMed
    Score: 0.024
  67. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 03; 340(8823):819-20.
    View in: PubMed
    Score: 0.023
  68. Kinsella JP, McQueston JA, Rosenberg AA, Abman SH. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am J Physiol. 1992 Sep; 263(3 Pt 2):H875-80.
    View in: PubMed
    Score: 0.023
  69. Watson RS, Clermont G, Kinsella JP, Kong L, Arendt RE, Cutter G, Linde-Zwirble WT, Abman SH, Angus DC. Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year. Pediatrics. 2009 Nov; 124(5):1333-43.
    View in: PubMed
    Score: 0.018
  70. Kunig AM, Parker TA, Nogee LM, Abman SH, Kinsella JP. ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. J Pediatr. 2007 Sep; 151(3):322-4.
    View in: PubMed
    Score: 0.016
  71. Grover TR, Rairigh RL, Zenge JP, Abman SH, Kinsella JP. Inhaled carbon monoxide does not cause pulmonary vasodilation in the late-gestation fetal lamb. Am J Physiol Lung Cell Mol Physiol. 2000 Apr; 278(4):L779-84.
    View in: PubMed
    Score: 0.010
  72. Dobyns EL, Griebel J, Kinsella JP, Abman SH, Accurso FJ. Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 1999 Jul; 28(1):24-30.
    View in: PubMed
    Score: 0.009
  73. Fagan KA, Fouty BW, Tyler RC, Morris KG, Hepler LK, Sato K, LeCras TD, Abman SH, Weinberger HD, Huang PL, McMurtry IF, Rodman DM. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest. 1999 Jan; 103(2):291-9.
    View in: PubMed
    Score: 0.009
  74. Ivy DD, Neish SR, Knudson OA, Nihill MR, Schaffer MS, Tyson RW, Abman SH, Shaffer EM, Valdes-Cruz L. Intravascular ultrasonic characteristics and vasoreactivity of the pulmonary vasculature in children with pulmonary hypertension. Am J Cardiol. 1998 Mar 15; 81(6):740-8.
    View in: PubMed
    Score: 0.008
  75. Kennaugh JM, Kinsella JP, Abman SH, Hernandez JA, Moreland SG, Rosenberg AA. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome. J Perinatol. 1997 Sep-Oct; 17(5):366-9.
    View in: PubMed
    Score: 0.008
  76. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, Abman SH, Kinsella JP. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr. 1997 Jul; 131(1 Pt 1):70-5.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)